Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- 510(k) (1)
- Advisory committee (1)
- American Law (1)
- Award of damages (1)
- Bargain test (1)
-
- Buyer (1)
- Civil Code Hidden Defect Warranty (1)
- Comparative Law (1)
- Duty to give notice (1)
- Elaborate regime of damages (1)
- Express Warranties Policy (1)
- Express remedies (1)
- Express warranties (1)
- FDA (1)
- Federal preemption (1)
- French Law (1)
- French civil code (1)
- Goods (1)
- Health law (1)
- Horizontal Privity Issue (1)
- International Law (1)
- Legal remedies (1)
- Magnusson-Moss Warranty Act (1)
- Medical device (1)
- Merchantability (1)
- Premarket notification (1)
- Product safety and liability (1)
- Products liability (1)
- Property law (1)
- Public information (1)
- Publication
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Torts
The Warranty Of Quality In Sale Of Goods Under The Perspective Of The American And French Law, Renaud Baguenault De Puchesse
The Warranty Of Quality In Sale Of Goods Under The Perspective Of The American And French Law, Renaud Baguenault De Puchesse
LLM Theses and Essays
While the United States’ common law system is characterized by diversity due to each state having its own set of rules, in certain areas there are nationwide legislative attempts of unification and standardization. One such attempt is the adoption of the Uniform Commercial Code which governs the sale of goods law in the United States. The French civil law system generally differs greatly from the American system in that it is primarily based upon statutes and codes. However, the American Uniform Commercial Code and the French Civil Code provide tangible, comparable bases to assess similarities and differences between American and …
Public Accountability And Medical Device Regulation, Robert B. Leflar
Public Accountability And Medical Device Regulation, Robert B. Leflar
Robert B Leflar
In enacting the Medical Device Amendments of 1976, Congress instituted a flexible system of regulatory controls over a vast array of health care products. Analyzing the complex statute and its legislative history, Professor Leflar finds at the law's core a structure designed to ensure the Food and Drug Administration's accountability to the public for its regulatory actions. Reviewing the history of FDA's implementation of the medical device law, however, the author demonstrates that FDA has strayed widely and, he contends, illegally from the congressionally mandated structure of public accountability. In particular, in its review of new-model medical devices in the …